Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$2.1 million.

  • Maravai Lifesciences Holdings' Other Working Capital Changes fell 59127.52% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.9 million, marking a year-over-year decrease of 16348.5%. This contributed to the annual value of -$6.3 million for FY2024, which is 6057.7% up from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Other Working Capital Changes stood at -$2.1 million for Q3 2025, which was down 59127.52% from -$6.2 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Working Capital Changes registered a high of $41.1 million during Q1 2021, and its lowest value of -$56.5 million during Q4 2021.
  • Over the past 5 years, Maravai Lifesciences Holdings' median Other Working Capital Changes value was -$1.6 million (recorded in 2023), while the average stood at -$3.7 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 223579.22% in 2021, then tumbled by 63826.09% in 2025.
  • Maravai Lifesciences Holdings' Other Working Capital Changes (Quarter) stood at -$56.5 million in 2021, then surged by 99.16% to -$475000.0 in 2022, then plummeted by 245.26% to -$1.6 million in 2023, then grew by 29.88% to -$1.2 million in 2024, then tumbled by 79.13% to -$2.1 million in 2025.
  • Its last three reported values are -$2.1 million in Q3 2025, -$6.2 million for Q2 2025, and -$8.5 million during Q1 2025.